- Supported exchanges /
- KQ /
- 950130.KQ
Access Bio Inc (950130 KQ) stock market data APIs
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. The company was incorporated in 2002 and is headquartered in Somerset, New Jersey.
Access Bio Inc Financial Data Overview
| 5780 | |
| 5550 | |
| - | |
| 5780 | |
| 5470 | |
| 5180-12140 | |
| 194 418 M | |
| 33 812 K | |
| 101 330 M | |
| -0.03 | |
| -0.029 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Access Bio Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 101 330 M
- EBITDA -18 520 281 088
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Access Bio Inc Earnings via APIs
- Latest Release 2017-08-11
- EPS/Forecast NaN
Get Access Bio Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
